Cellular therapies in ARDS

نویسندگان

چکیده

Acute respiratory distress syndrome (ARDS) is a critical illness characterized by severe hypoxemic failure, caused an inflammatory response which results in diffuse lung damage. Despite decades of research, the treatment ARDS remains supportive. However, recent years, cell-based therapies have been subject intensive ongoing research efforts, showing relevant therapeutic potential preclinical models. Among all different cells that identified as suitable candidates for use, mesenchymal stromal (MSCs) most attractive and generated significant interest. MSCs are multipotent adult stem/stromal can modulate immune enhance repair damaged tissue multiple vivo Their promising effect seems to be not primarily mediated differentiation engraftment but more paracrine release soluble mediators cellular components such extracellular vesicles (EVs). Preclinical experiments provided encouraging evidence MSCs, leading launch several phase I II clinical trials shown safety ARDS, became very common nowadays due Coronavirus disease (COVID-19) pandemic. some translational challenges yet solved, reproducibility cell harvest, storage, reconstitution, administration cells/cell-products, before stem realized.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

New therapies for acute respiratory distress syndrome (ARDS):--a review.

Acute respiratory distress syndrome (ARDS) has been associated with high mortality. Improved understanding of the pathophysiology, recognition of precipitating events and improved management has decreased the mortality over the years. Mechanical ventilation is still the corner stone of the management of the disease. It is well recognised that high tidal volumes and airway pressures increase the...

متن کامل

Cellular Therapies in Systemic Sclerosis: Recent Progress.

Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease with a high mortality and morbidity. While progress has been made in terms of identifying high-risk patients and implementing new treatment strategies, therapeutic options remain limited. In the past few decades, various cellular therapies have emerged, which have been studied in SSc and other conditions. Here, we provide a...

متن کامل

Perspectives in transfusion medicine and cellular therapies.

ticular, represent novel therapeutic approaches in the attempt to reverse disease progression and to cure patients in the long term. The latest advances in these fields raise hope for many patients. Specialists in transfusion medicine are encouraged to get more involved to help improving the practice and standardization of cellular therapies such as the so-called advanced therapeutical medicina...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Signa Vitae

سال: 2022

ISSN: ['1334-5605', '1845-206X']

DOI: https://doi.org/10.22514/sv.2022.059